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Bio-catalytic nanocompartments for in situ production of glucose-
6-phosphate  
M. Lomora,a G. Gunkel-Grabolea, S. Mantrib and C. G. Palivan*a 
Cells are sophisticated biocatalytic systems driving a complex 
network of biochemical reactions. A bioinspired strategy to create 
advanced functional systems is to design confined  spaces for 
complex enzymatic reactions by using a combination of synthetic 
polymer assemblies and natural cell components. Here, we 
developed bio-catalytic nanocompartments that contain 
phosphoglucomutase protected by a biomimetic polymer 
membrane, which was permeabilized for reactants through 
insertion of an engineered α-hemolysin pore protein. These bio-
catalytic nanocompartments serve for production of glucose-6-
phosphate, and thus possess great potential for applications in an 
incomplete glycolysis, pentose phosphate pathway, or in plant 
biological reactions.  
Mimicking natural cellular compartments and their 
function is a very promising bio-inspired strategy to develop 
multifunctional systems. Particularly, synthetic bio-catalytic 
nanocompartments (CatCs) based on polymer membrane 
enclosed cavities (polymer vesicles or polymersomes) are of 
interest. These can contain active compounds (enzymes, 
proteins, mimics) performing reactions in situ.1,2 The reaction 
nanospaces inside CatCs are ideal for the study of 
sophisticated enzyme-based biocatalytic processes, such as 
energy production, creation of artificial organelles, or minimal 
protocells with wide application potential.1,3 This can be 
realized through  appropriate selection of active compounds to 
serve the desired application through their intrinsic 
functionality and use of polymersomes with mechanical 
stability and tunable properties (compartment size and 
morphology, membrane thickness, permeability, flexibility, 
and/or stimuli-responsiveness). The polymer membrane offers 
protection of encapsulated active compounds (enzymes), e.g. 
against degradation, hence it needs to preserve its 
architecture and at the same time allow passage of reaction 
substrates and products.4 
  Different strategies have been introduced to obtain 
permeable synthetic membranes:5,6 polymers with intrinsically 
porous membranes,7 stimuli-triggered transition of the 
membrane permeability8 and insertion of natural membrane 
proteins similarly to permeabilization of cell membranes.9 For 
instance, CatCs from carbohydrate-b-poly(propylene glycol) 
possess tunable permeability owing to the membrane 
hydrophobicity.10 Alternatively, UV-crosslinked CatCs can 
undergo a controllable swelling (permeable state) – deswelling 
transition.11 The biomimetic approach that stands out is the 
permeabilisation of the CatCs through insertion of biopores, as 
for example gramicidin12 and natural membrane proteins 
(MPs) such as outer membrane protein (OmpF)13 or FhuA14 in 
the polymer membrane. Research has shown that a 
combination of flexible polymers and appropriate membrane 
thickness are necessary for a successful insertion of biopores 
and membrane proteins in synthetic membranes. Flexible 
polymers allow protein insertion also in  membranes that are 
significantly thicker than lipid bilayers and cell membranes.15,16 
Therefore, if the synthetic membrane is not sufficiently 
flexible, MPs can only be inserted in membranes that are very 
similar to a phospholipid bilayer (approximately 5 nm 
thickness),16,17 as it has been reported for α-hemolysin 
insertion in the membrane of polybutadiene-block-
polyethyleneoxide (PEO12-b-PBD21) based polymer vesicles.18 
Among synthetic block-copolymers, polydimethylsiloxane-
based polymers (e.g. PMOXA-b-PDMS-b-PMOXA) satisfy these 
key requirements well, as has been demonstrated by 
successful insertion of various biopores and MPs in 
polymersome membranes.5,16  
This study focuses on PMOXA-b-PDMS-b-PMOXA CatCs 
that are permeabilized through insertion of a genetically 
engineered α-hemolysin (α-HL) (see ref.19 for details on the 
membrane protein) to allow substrate entry and product exit 
through the CatC polymer membrane. The pore of engineered 
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α-HL allows passage of molecules of up to 4 kDa in molecular 
weight,20 whilst keeping an enzyme-based catalyst 
encapsulated within the CatCs (Fig. 1 and Fig. S1 ESI). 
Importantly, insertion of this genetically engineered α-HL was 
shown in liposomes and planar lipid membranes only,19 its 
insertion in significantly larger synthetic polymer membranes 
is proven for the first time here. The CatCs prepared serve for 
production of glucose-6-phosphate (G6P), as for the first time 
phosphoglucomutase (PGM) was encapsulated inside a 
polymeric nanocompartment’s cavity, thereby providing 
essential protection of the enzyme from degradation. PGM is 
an essential enzyme in the carbohydrate metabolism, which 
catalyses conversion of glucose-1-phosphate (G1P) to the 
product glucose-6-phosphate (G6P).  Lack or reduced activity 
of PGM has been attributed to impaired plant growth and 
development.21,22 In addition, PGM along with glucose-6-
phosphate dehydrogenase (G6PDH) is crucial for the 
generation of energy and formation of nicotinamide adenine 
dinucleotide phosphate (NADPH), a reducing agent with a vital 
role in biological reactions. PGM is also an essential enzyme 
with major implications in metabolic pathways. In human 
disorders, the lack of PGM or its reduced activity has been 
attributed to glycogen storage diseases.21,22   
   
Fig. 1 Schematic illustration of the bio-catalytic nanocompartment with 
encapsulated phosphoglucomutase (yellow) for the conversion of glucose-1-
phosphate (blue filled circle) to the product glucose-6-phosphate (grey filled 
circle) (A). Transmission electron microscopy (TEM) of the CatCs made by 
rehydration of PMOXA6PDMS34PMOXA6 polymer film with 55 µg/mL 
phosphoglucomutase (PGM). Scale bar: 200 nm (B).  
 CatCs were formed via self-assembly of poly(2-
methyloxazoline)6-block-poly(dimethylsiloxane)34-block-poly(2-
methyloxazoline)6, designated as PMOXA6-b-PDMS34-b-
PMOXA6 triblock-copolymer (molecular weight: Mw = 3.8 
kg/mol, dispersity: Đ = 2.3, hydrophilic weight fraction: 
fhydrophilic = MPMOXA/Mw = 32% - suitable to form vesicular 
structures in aqueous solutions),15 using a typical film 
rehydration method.12 Specifically, they were produced by 
rehydrating a block copolymer thin film with the enzyme 
cocktail mixture overnight (see experimental details in ESI), 
followed by extrusion through 200 nm pore filters and 
separation of the CatCs from the non-encapsulated PGM via 
dialysis.  
 Transmission electron micrographs (TEM) confirmed 
formation of spherical structures with a diameter of 100-200 
nm in the presence of PGM, similar to the self-assembly 
observed of pure polymersomes (Fig. 1 B and S2 ESI). 
Additionally, light scattering data confirmed the size of around 
160 nm of the spherical structures observed in TEM (Fig. S3 
ESI). Moreover, no significant change in size was observed in 
the CatCs containing PGM with 6.12x10-4% sodium dodecyl 
sulphate (SDS) or with 0.7 µg/mL engineered α-HL, confirming 
the stability of this bio-catalytic nanocompartment. SDS used 
to solubilize the engineered α-HL neither affected the function 
of engineered α-HL19 nor the architecture of the 
polymersomes.  
 PGM encapsulation in the cavity of the CatCs was 
determined by fluorescence correlation (FCS) spectroscopy12,23 
using PGM labelled with ATTO488 (Fig. S4 ESI). A diffusion time 
of τ ≈ 29 μs for the ATTO488 free dye in solution (Fig. 2, blue 
curve) was obtained from analysis of the FCS autocorrelation 
curves. Labelling PGM with the ATTO488 fluorophore (PGM-
ATTO488), leads to an increase in diffusion time to 153 μs (Fig. 
2, green curve), which indicated the presence of labelled 
enzymes. When the dye-labelled enzyme was encapsulated 
within CatCs (PGM-ATTO488 NRs), the architecture of CatCs 
was not affected (Fig. S5 ESI) and a diffusion time of ≈3 ms was 
obtained (Fig. 2, grey curve) indicating that the labelled 
enzyme is indeed encapsulated within the CatCs.  
 During encapsulation of PGM-ATTO488 inside CatCs (see 
Methods in ESI) some free PGM-ATTO488 molecules remain 
outside of the CatCs that are subsequently removed by 
dialysis. To confirm removal of non-encapsulated PGM-
ATTO488, FCS autocorrelation curves were fitted using a two 
component model, which allowed to identify the percentage 
of species with fast diffusion time (non-encapsulated PGM-
ATTO488) and the percentage of species with a slow diffusion 
time (PGM-ATTO488 encapsulated within the CatCs).24 These 
FCS measurements confirmed that non-encapsulated PGM-
ATTO488 was completely removed via dialysis:  >99.99% of the 
diffusive fraction correlates with the diffusion time of τ ≈ 3018 
μs (PGM-ATTO488 CatCs), while only a negligible remainder 
fraction correlates with the diffusion time of τ ≈ 153 μs (PGM-
ATTO488).   
Fig. 2 FCS auto-correlation curves of free dye ATTO-488 (blue curve), PGM-
ATTO488 conjugate (green curve), CatCs loaded with PGM-ATTO488 conjugate 
(grey curve), pH = 7.5, RT.  
 The PMOXA6-b-PDMS34-b-PMOXA6 membrane itself is not 
permeable to the substrates and products of this reaction, it is 
only permeable to reactive oxygen species.25 Hence, the 
membrane was permeabilised with an engineered α-HL (SDS 
page characterisation in Fig. S6 ESI). The activity of α-HL was 
tested using synthetic liposomes as a model system and a dye 
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leakage assay.26 Carboxyfluorescein (CF, ʎexc = 495 nm/ʎem = 
517 nm) was encapsulated in liposomes at a concentration of 
50 mM where its fluorescence is quenched. Upon addition of 
α-HL, the release and thus dilution of CF led to a colour change 
from brown to green-yellow, confirming permeabilization (full 
characterisation of the liposomes can be found in the Fig. S7 
ESI).  
 Subsequently, permeabilization of PMOXA6-b-PDMS34-b-
PMOXA6 polymersomes containing CF was performed under 
similar conditions to identify whether the engineered α-HL is 
able to insert into polymer membranes as well (Fig. S8 ESI). We 
observed that α-HL insertion was considerably more difficult in 
the case of synthetic membranes because they are significantly 
thicker (9.2 nm)15 than the liposome lipid bilayer (5 nm). It has 
been reported that a high flexibility of the membrane is 
necessary to overcome the hydrophobic mismatch between 
the pore size and the membrane thickness and allow 
functional insertion of membrane pores, hence this particular 
copolymer was selected.16 Again, a colour change from light 
brown to light green-yellow was observed after addition of the 
engineered α-HL as for liposomes, indicating successful 
insertion and membrane permeabilisation (Fig. S8A ESI). Upon 
the addition of the 1.3 µg/mL α-HL, TEM revealed similar 
vesicular structures with a diameter of ca. 100-200 nm as 
before (Fig. S8B ESI). After α-HL addition (at around 150-200 s, 
indicated by the orange arrow), dye leakage and increase in 
fluorescence upon release from the polymersomes was 
observed after 100-200 s (light blue curve in Fig. 3A). This time 
delay can be explained, because of the increased membrane 
thickness of the polymer membrane.15 The results showed that 
the engineered α-HL is able to successfully insert in the 
polymer membrane of our nanocompartments. Additional 
experiments proved that membrane integrity of the 
nanocompartments is also maintained in presence of 
solubilisation buffer for engineered α-HL, which contained a 
low concentration of SDS (red curve in Fig. 3A and Figs. S9-11 
ESI).  
Further insight into the insertion of engineered α-HL in the 
membrane of the polymersomes was obtained with 
fluorinated-amphiphiles (F-amphiphiles), which hinder α-HL 
pore insertion into lipid membranes when used at 
concentrations above their CMC.26 Commercially available 
FOS-choline (FFC) with a C6F13C2H4 single chain was shown not 
to interfere with lipid membrane integrity.26 When FFC 
molecules are used at approximately 5 times their CMC, they 
stop further insertion of α-HL in liposome membranes without 
affecting the bilayer stability or functionality of the already 
inserted α-HL. 
Similar experiments with PMOXA6-b-PDMS34-b-PMOXA6 
polymersomes revealed that α-HL insertion in the polymer 
membranes is also impeded when 10 mM fluorinated FOS-
choline (FFC) is added to the polymersomes before addition of 
the engineered α-HL (Fig. 3B, blue curve). If the engineered α-
HL is added first, it inserts and encapsulated dye is released 
until the F-amphiphile is added (indicated by an arrow in Fig. 
3B green curve). 10 mM FFC aggregates (visualised by TEM in 
Fig. S12 ESI) blocked further insertion of engineered α-HL into 
polymersome membrane. Moreover, these exciting results 
provide a platform to control the number of functional 
engineered α-HL pores in more stable polymer membranes.  
Fig. 3 A. After the addition of 1.3 µg/mL of engineered α-HL (after around 150-
200 s, as indicated by the orange arrow), dye release and increase in 
fluorescence upon dilution from the polymersomes was observed after 100-200 
s (light blue curve). No dye was released upon addition of SDS only (without 
engineered α-HL) during 2000 s (red curve). The black curve represents only the 
polymersomes, without any SDS or engineered α-HL, to identify the initial 
fluorescence of polymersomes due to the encapsulated dye. * 
B. Addition of 10 mM F-amphiphile before (blue curve) and after insertion (as 
indicated by arrows) of engineered α-HL in the membrane of A6B34A6 
polymersomes containing the encapsulated CF.* 
*Experiments were carried out in 300 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 
mM KH2PO4 (Buffer C, see ESI for details) at pH = 8.0, RT.  
 Production of G6P was detected using an established 
glucose-6-dehydrogenase (G6PDH) enzyme coupled assay. 
Enzymatic activity of free and encapsulated PGM was 
determined by spectrophotometric monitoring of the 
production of NADPH (ʎexc = 340 nm/ʎem = 460 nm, for 
complete enzymatic conversion steps see Fig. S1).27 NADPH 
was produced only when the G1P substrate was present in the 
enzyme cocktail mixture (Fig. S13 ESI). Typically, after addition 
of G1P an initial sharp and then gradual increase of 
fluorescence intensity due to formation of NADPH was 
observed. This confirms successful permeabilization of the 
membrane with α-HL and activity of the CatC (Fig. 4, purple 
curve). 
Importantly, when just SDS and no α-HL was used, only the 
initial increase was observed when G1P was added followed by 
steady fluorescence intensity (Fig. 4, black curve). The 
fluorescence remained stable for up to 5000 s, showing that 
the G1P substrate cannot cross the CatC membrane without 
presence of α-HL and thus cannot initiate the reaction. 
Furthermore, CatCs containing 10 times higher amount of 
PGM showed activity as well (Fig. 14 ESI). 
 Fig. 4 Activity of the CatCs with encapsulated phosphoglucomutase in the 
absence (black curve) and presence (blue curve) of engineered α-hemolysins (pH 
= 7.5, RT). CatCs are successfully permeabilised due to the higher increase in 
fluorescence intensity in the presence of engineered α-HL (blue curve), as 
compared with the pore absence (black curve).  
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 We successfully designed polymer CatCs by encapsulation 
of PGM and permeabilization of the polymer membrane using 
genetically engineered α-HL pore protein. Importantly, the 
pore protein only facilitates transport of small molecules like 
G1P and G6P through the membrane, while the enzyme 
remains entrapped and protected. The product G6P was 
detected with a G6PDH-coupled enzyme assay via the 
formation of fluorescent NADPH. G6P is a relevant metabolic 
compound, which may aid in an incomplete glycolysis, pentose 
phosphate pathway, or in plant biological reactions. 
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